Hospitals lead the AI-driven cardiac diagnostics market at 33.5% share by end user, followed by arrhythmia detection at 31.4% by application and machine learning at 30.5% by technology. Demand centers on faster and more accurate cardiac diagnosis, while clinical validation and regulatory requirements remain key constraints.